Post by Dana-Farber Cancer Institute

Brian Wolpin, MD, MPH, spoke with WBUR’s Meghna Chakrabarti about promising new research, led by Wolpin and his team, showing daraxonrasib significantly extended survival for patients with previously treated metastatic pancreatic cancer. Listen here. ⬇️